MediFind
Condition

Hospital-Acquired Pneumonia

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Intubation-Associated Pneumonia
  • Journal: BMC anesthesiology
  • Treatment Used: TaperGuard Endotracheal Tube
  • Number of Patients: 15388
  • Published —
This study tested the safety and efficacy of using a TaperGuard endotracheal tube to prevent patients from acquiring postoperative pneumonia.
Latest Advance
Study
  • Condition: Complicated Urinary Tract Infection, Complicated Intra-Abdominal Infection and/or Nosocomial Pneumonia, including Ventilator-Associated Pneumonia in Adults
  • Journal: Drug safety
  • Treatment Used: Avibactam
  • Number of Patients: 4050
  • Published —
The study researched the safety of Avibactam.
Latest Advance
Study
  • Condition: Eosinophilic Cholecystitis with Common Bile Duct Sludge and Cholangitis
  • Journal: JNMA; journal of the Nepal Medical Association
  • Treatment Used: Cholecystectomy and Common Bile Duct Exploration
  • Number of Patients: 1
  • Published —
This case report describes a 27-year female diagnosed with eosinophilic cholecystitis (gallbladder inflammation) and cholangiopathy (common bile duct disease) treated with cholecystectomy and common bile duct exploration.
Latest Advance
Study
  • Condition: Hospital Acquired Pneumonia
  • Journal: Critical care (London, England)
  • Treatment Used: Meropenem Continuous Infusion
  • Number of Patients: 31
  • Published —
This study evaluated the pharmacokinetics of two doses of meropenem (3?g vs 6?g/day by continuous infusion) in the plasma and epithelial lining fluid (ECF) in critically ill patients with nosocomial pneumonia.
Latest Advance
Study
  • Condition: Pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan
  • Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
  • Treatment Used: Vancomycin
  • Number of Patients: 199
  • Published —
The study researched treatments, outcomes, and characteristics for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan.
Latest Advance
Study
  • Condition: Nosocomial Pneumonia
  • Journal: The Lancet. Infectious diseases
  • Treatment Used: Ceftolozane-Tazobactam vs. Meropenem
  • Number of Patients: 726
  • Published —
This study compared the effectiveness and safety of ceftolozane-tazobactam with meropenem for treatment of nosocomial (acquired in a hospital) pneumonia.
Latest Advance
Study
  • Condition: Carbapenem-Nonsusceptible Infections
  • Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Treatment Used: Imipenem/Relebactam
  • Number of Patients: 31
  • Published —
The study researched the safety and effectiveness of Imipenem/Relebactam for patients with carbapenem-nonsusceptible infections.
Latest Advance
Study
  • Condition: Urinary tract infection
  • Journal: The Lancet. Infectious diseases
  • Treatment Used: Cefiderocol versus Imipenem-Cilastatin
  • Number of Patients: 448
  • Published —
This study assesses the efficacy and safety of Cefiderocol versus Imipenem-Cilastatin for the treatment of complicated urinary tract infection in patients at risk of multidrug-resistant Gram-negative infections.
Latest Advance
Study
  • Condition: Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) Caused by Multi-Drug-Resistant (MDR) Klebsiella Pneumoniae
  • Journal: Journal of global antimicrobial resistance
  • Treatment Used: High-Dose Colistin Monotherapy vs. Colistin-Meropenem Combination Therapy
  • Number of Patients: 60
  • Published —
This study evaluated the effectiveness and adverse effects of using colistin alone at a loading dose of 9 million international units (MIU) followed by 3 MIU every 8h (q8h) versus colistin+meropenem 1g q8h in treating multi-drug-resistant (MDR) Klebsiella pneumoniae-induced hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP). The primary outcome measure was in-hospital mortality. The secondary measure was the occurrence of colistin toxicity.
Latest Advance
Study
  • Condition: Patients With Infections Caused by Klebsiella Pneumoniae Carbapenemase-Producing K. Pneumoniae
  • Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Treatment Used: Ceftazidime-Avibactam Salvage Therapy (CAZ-AVI)
  • Number of Patients: 138
  • Published —
This study reviewed cases of infections caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-Kp) in adults who received ceftazidime-avibactam (CAZ-AVI).
Latest Advance
Study
  • Condition: Hospital Acquired Pneumonia (HAP)
  • Journal: International journal of antimicrobial agents
  • Treatment Used: Carbapenems vs. alternative ?-lactams
  • Number of Patients: 1273
  • Published —
Carbapenems have shown efficacy in treating nosocomial pneumonias. The aim of this review was to identify any differences in outcomes potentially as a function of decreased penetration.